Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Shares Issued (2021 - 2025)

Verrica Pharmaceuticals (VRCA) has 4 years of Shares Issued data on record, last reported at $50.1 million in Q4 2025.

  • For Q4 2025, Shares Issued rose 18.23% year-over-year to $50.1 million; the TTM value through Dec 2025 reached $50.1 million, up 17.8%, while the annual FY2025 figure was $50.1 million, 17.8% up from the prior year.
  • Shares Issued reached $50.1 million in Q4 2025 per VRCA's latest filing, up from $42.3 million in the prior quarter.
  • Across five years, Shares Issued topped out at $50.1 million in Q4 2025 and bottomed at -$27.6 million in Q3 2021.
  • Average Shares Issued over 4 years is $13.4 million, with a median of $150000.0 recorded in 2024.
  • Peak YoY movement for Shares Issued: plummeted 42.86% in 2024, then rose 18.23% in 2025.
  • A 4-year view of Shares Issued shows it stood at $27.6 million in 2021, then crashed by 99.97% to $7000.0 in 2023, then soared by 604857.14% to $42.3 million in 2024, then increased by 18.23% to $50.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $50.1 million in Q4 2025, $42.3 million in Q4 2024, and $150000.0 in Q2 2024.